First pharmacophore-based identification of androgen receptor down-regulating agents: Discovery of potent anti-prostate cancer agents-Reference-Cited by-同舟云学术

First pharmacophore-based identification of androgen receptor down-regulating agents: Discovery of potent anti-prostate cancer agents

Published:2007-05 Issue:10 Volume:15 Page:3413-3421
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Purushottamachar Puranik,Khandelwal Aakanksha,Chopra Pankaj,Maheshwari Neha,Gediya Lalji K.,Vasaitis Tadas S.,Bruno Robert D.,Clement Omoshile O.,Njar Vincent C.O.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference38 articles.

1. Cancer Statistics 2005; American Cancer Society: Washington, DC, 2006.

2. A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma

3. Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Approaches: A New Frontier in Cancer Research;Combinatorial Chemistry & High Throughput Screening;2023-11-28

2. Virtual Screening of Natural Products Database;Mini-Reviews in Medicinal Chemistry;2021-11-23

3. Characterization and catalytic performance of Ni-Doped TiO2 as a potential heterogeneous nanocatalyst for the preparation of substituted pyridopyrimidines;Journal of Molecular Structure;2020-03

4. PHYTOTHERAPY PHARMACOPHORES FOR MAJOR CELLULAR DRUG TARGETS;Phytotherapies;2015-04-24

5. Virtual screening strategies: Recent advances in the identification and design of anti-cancer agents;Methods;2015-01